| Literature DB >> 34268395 |
Yu-Ping Yang1, Shuo Yuan1, Guo-Qing Cui1, Ning An1, Ying-Fang Ao1.
Abstract
BACKGROUND: The extracapsular subcutaneous endoscopic treatment is a new and under-researched approach to the endoscopic treatment of refractory lateral epicondylalgia. We aimed to introduce the techniques of the method and the mid-long term clinical effects. Furthermore, we intended to identify demographic and surgical-related factors correlated with prognosis of extracapsular subcutaneous method.Entities:
Keywords: Refractory lateral epicondylalgia (RLE); endoscopy; extracapsular method; intracapsular method; prognostic factors
Year: 2021 PMID: 34268395 PMCID: PMC8246197 DOI: 10.21037/atm-20-6799
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Figure 1Preoperative and 6-month postoperative coronal proton density-weighted fat-saturated MR images obtained in a 46-year-old woman. (A) A region of increased signal intensity due to fluid accumulation at the site of the expected ECRB tendon origin (arrow); a small partial-thickness tear of the CEO can also be noticed. (B) Fluid accumulation was significantly decreased 6 months after surgery; no obvious tear was found (arrowhead).
Figure 2Patient position and location of incisions. (A) Supine position was adopted for the extracapsular method; the affected elbow was placed on the chest with a gas tourniquet. (B) The lateral epicondyle was probed with a needle, and two incisions (0.5 cm in length) were made 3 cm proximal and distal of the lateral epicondyle.
Figure 3Tendon tear suture operation. (A) An obvious tendon tear. (B) Tear was sutured under endoscopy using PDS suture and 3-0 antibacterial Vicryl absorbable suture.
Figure 4Pathological analysis of degenerative tendon tissue. (A) Synovial tissue. Interstitial connective tissue hyperplasia, focal vascular proliferation, focal necrosis with foam cell formation, and foreign body giant cell response. (B) Tissue from extensor carpi radialis brevis. Dense connective tissue and small vessel hyperplasia with a small amount of chronic inflammatory cell infiltration. Hematoxylin-eosin staining, magnification: ×10.
Baseline characteristics of study population (n=75)
| Baseline characteristics | Study population (n=75) |
|---|---|
| No. of Elbows | 75 |
| Age (yr) | 45.4 (SD, 6.4) |
| Women | 43 (57.3%) |
| BMI | 24.1 (SD, 3.3) |
| Duration (mo) | 16.2 (13.1, 22.5) |
| Right Elbow | 53 (70.7%) |
| Dominant Elbow | 38 (50.7%) |
| History of trauma | 15 (20%) |
| History of glucocorticoid injection | 65 (86.7%) |
Comparison of VAS, MEPS and DASH score between preoperative and last follow-up [n=75, mean (quartile 1 Q1, quartile 3 Q3)]
| VAS | MEPS | DASH | |
|---|---|---|---|
| Preoperative | 7.0 (7.0, 7.0) | 60.0 (47.0, 68.0) | 44.2 (29.2, 65.0) |
| Last follow-up | 0.0 (0.0, 1.0) | 100 (99.0, 100.0) | 0.13 (0.0, 0.8) |
| Z value | −7.493 | −7.478 | −7.525 |
| P value | 0.000 | 0.000 | 0.000 |
Univariable and multivariable analysis for postoperative patients-reported outcome measures
| Score (CR/IR) | Prognostic factors | CR | IR | t/χ2/Z value | P value | Adjusted OR (95% CI) | Adjusted P value |
|---|---|---|---|---|---|---|---|
| VAS (43/32) | PVASa | 6.1±2.0 | 6.7±1.6 | t=−1.045 | 0.3 | 0.823 (0.614–1.103) | 0.193 |
| Sexc | 19 (44.2%) | 13 (40.6%) | χ2=0.095 | 0.758 | 1.065 (0.373–3.036) | 0.907 | |
| Agea | 44.0±6.5 | 47.4±5.8 | t=−2.327 | 0.023 | 0.914 (0.842–0.993) | 0.033 | |
| NGIb | 3.0 (1.0, 4.0) | 2.0 (1.0, 3.0) | Z=−0.641 | 0.521 | 0.998 (0.809–1.231) | 0.987 | |
| MFc | 10 (23.2%) | 3 (9.3%) | χ2=2.467 | 0.116 | 0.542 (0.081–3.606) | 0.526 | |
| Suturec | 20 (46.5%) | 14 (43.8%) | χ2=0.056 | 0.812 | 1.426 (0.484–4.204) | 0.52 | |
| PCFc | 15 (34.9%) | 6 (18.8%) | χ2=2.369 | 0.124 | 0.437 (0.100–1.910) | 0.271 | |
| Mayo (55/20) | PMEPSa | 58.2±18.1 | 55.7±20.3 | t=0.509 | 0.613 | 0.999 (0.969–1.031) | 0.961 |
| Sexc | 25 (45.5%) | 7 (35.0%) | χ2=0.655 | 0.418 | 1.576 (0.492–5.049) | 0.444 | |
| Agea | 44.7±6.4 | 47.4±6.1 | t=−1.618 | 0.11 | 0.942 (0.862–1.029) | 0.183 | |
| NGIb | 2.0 (1.0, 4.0) | 2.0 (1.0, 3.8) | Z=−0.140 | 0.889 | 0.963 (0.776–1.196) | 0.736 | |
| MFd | 11 (20.0%) | 2 (10.0%) | χ2=0.445 | 0.505 | 0.364 (0.043–3.041) | 0.35 | |
| Suturec | 25 (45.5%) | 9 (45.0%) | χ2=0.001 | 0.972 | 1.223 (0.392–3.820) | 0.728 | |
| PCFc | 16 (29.1%) | 5 (25.0%) | χ2=0.122 | 0.727 | 1.203 (0.260–5.573) | 0.814 | |
| DASH (32/43) | PDASHa | 46.0±25.9 | 50.7±24.4 | t=−0.799 | 0.427 | 1.003 (0.980–1.025) | 0.822 |
| Sexc | 16 (50.0%) | 16 (37.2%) | χ2=1.227 | 0.268 | 2.228 (0.716–6.931) | 0.167 | |
| Agea | 43.9±6.5 | 46.6±6.1 | t=−1.819 | 0.073 | 0.945 (0.871–1.025) | 0.17 | |
| NGIb | 3.0 (1.0, 4.0) | 2.0 (1.0, 3.0) | Z=−0.897 | 0.37 | 1.187 (0.958–1.470) | 0.117 | |
| MFc | 7 (21.9%) | 6 (14.0%) | χ2=0.803 | 0.37 | 0.056 (0.004–0.783) | 0.032 | |
| Suturec | 15 (46.9%) | 19 (44.2%) | χ2=0.054 | 0.817 | 1.102 (0.355–3.419) | 0.886 | |
| PCFc | 7 (21.9%) | 14 (32.6%) | χ2=1.039 | 0.308 | 11.156 (1.009–123.363) | 0.049 |
Test of normality for continuous variables. The distributions of age, PVAS, PMEPS and PDASH are normal and described as mean standard deviation, and the independent sample t test was used to compare the variables between different outcomes (a); NGI are not normally distributed and are described by median and quartile, and the Mann-Whitney U test was used to compare the differences of PVAS between different outcomes (b). For the two-category variables, cases without microfracture, suture, or plaster cast fixation are the reference groups, and the proportion of patients with these is provided. When comparing two categorical variables between two outcomes, the Pearson χ2 test (c) or the continuous correction χ2 test (d) was adopted according to the expected value of the four-fold table. CR, complete recovery; IR, incomplete recovery; PVAS, preoperative VAS; PMEPS, preoperative MEPS; PDASH, preoperative DASH; NGI, number of glucocorticoid injections; MF, microfracture; PCF, plaster cast fixation.